First-in-Human Diabetes Cell Therapy: Cedars-Sinai’s Hypoimmune Approach Enters Clinical Testing July 24, 2026 Read More »
Cell-Based Therapy for Diabetes: Avaí Bio Secures a Key Supplier for Insulinova July 21, 2026 Read More »
Longeveron Laromestrocel Therapy Shows Promise for Alzheimer’s Inflammation July 13, 2026 Read More »
Kenai Therapeutics Completes Phase 1b/2a Trial Enrollment for Parkinson’s Cell Therapy July 7, 2026 Read More »
